The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARVINAS INC | COM | 04335A105 | 12,780 | 287,251 | SH | SOLE | 287,251 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 12,402 | 188,228 | SH | SOLE | 188,228 | 0 | 0 | ||
| C4 THERAPEUTICS INC | COM STK | 12529R107 | 3,296 | 375,857 | SH | SOLE | 375,857 | 0 | 0 | ||
| CULLINAN ONCOLOGY INC | COM | 230031106 | 15,655 | 1,221,145 | SH | SOLE | 1,221,145 | 0 | 0 | ||
| EQRX INC | COM | 26886C107 | 64,867 | 13,104,424 | SH | SOLE | 13,104,424 | 0 | 0 | ||
| KINNATE BIOPHARMA INC | COM | 49705R105 | 31,810 | 2,661,888 | SH | SOLE | 2,661,888 | 0 | 0 | ||
| KRONOS BIO INC | COM | 50107A104 | 4,863 | 1,451,537 | SH | SOLE | 1,451,537 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 18,432 | 263,914 | SH | SOLE | 263,914 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 16,491 | 1,385,807 | SH | SOLE | 1,385,807 | 0 | 0 | ||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 10,637 | 475,485 | SH | SOLE | 475,485 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 82,618 | 4,189,529 | SH | SOLE | 4,189,529 | 0 | 0 | ||
| SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 10,085 | 1,910,029 | SH | SOLE | 1,910,029 | 0 | 0 | ||
| THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 3,546 | 611,310 | SH | SOLE | 611,310 | 0 | 0 | ||
| TYRA BIOSCIENCES INC | COM | 90240B106 | 22,138 | 2,518,582 | SH | SOLE | 2,518,582 | 0 | 0 | ||